Managing mental illness in Ghana: The state of commonly prescribed psychotropic medicines

International Journal of Mental Health Systems

Volumn 10, Issue 1, 2016, Pages

  Oppong, Samuel ^a   Kretchy, Irene A ^a   Imbeah, Emelia P ^a   Afrane, Barima A ^a  

^a UNIVERSITY OF GHANA   (Ghana)

Author keywords

Anticonvulsants; Antidepressant; Antipsychotics; Anxiolytics; Ghana; Hypnosedatives; Mental illness; Psychotropic medications

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZATROPINE; CARBAMAZEPINE; CHLORPROMAZINE; CITALOPRAM; CLOZAPINE; DIAZEPAM; FLUOXETINE; HALOPERIDOL; HYPNOTIC SEDATIVE AGENT; IMIPRAMINE; LAMOTRIGINE; LITHIUM CARBONATE; LITHIUM SALT; LORAZEPAM; NEUROLEPTIC AGENT; OLANZAPINE; PHENOBARBITAL; PHENYTOIN; QUETIAPINE; RISPERIDONE; SERTRALINE; THIORIDAZINE; TOPIRAMATE; TRIFLUOPERAZINE; TRIHEXYPHENIDYL; UNINDEXED DRUG; VALPROIC ACID;

ARTICLE; CONTROLLED STUDY; DRUG COST; DRUG QUALITY; FEMALE; GHANA; HEALTH CARE AVAILABILITY; HEALTH CARE FINANCING; HUMAN; MALE; MEDICAL ASSISTANT; MENTAL DISEASE; NURSE; PHARMACIST; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; PSYCHIATRIST; PSYCHOPHARMACOTHERAPY; QUALITATIVE RESEARCH; SEMI STRUCTURED INTERVIEW;

EID: 84962069503     PISSN: None     EISSN: 17524458     Source Type: Journal    
DOI: 10.1186/s13033-016-0061-y     Document Type: Article

References (15)

1. World Health Organization. Mental health: a state of well-being 2013. Available: http://www.who.int/features/factfiles/mental_health/en/. Accessed 2 Nov 2013.
2. World Health Organization. WHO-AIMS report on mental health system in Ghana 2011.
3. Patel V, Araya R, Bolton P. Treating depression in the developing world. Trop Med Int Health. 2004;9(5):539-41.
4. World Health Organization. Pharmacological treatment-guidelines of mental disorders in primary health care. In: WHO, editor. WHO library cataloguing-in-publication data. Geneva: WHO Press; 2009.
5. Roberts M, Mogan C, Asare JB. An overview of Ghana's mental health system: results from an assessment using the World Health Organization's Assessment Instrument for Mental Health Systems (WHO-AIMS). Int J Ment Health Syst. 2014;8:16.
6. Mcbaine R, Norton DJ, Morris J, Yasamy MT, Betancourt TS. The role of health systems factors in facilitating access to psychotropic medicines: a cross-sectional analysis of the WHO-AIMS in 63 low- and middle-income countries. PLoS Med. 2012;9:e1001166.
7. Alderman C, Edward K. Psychopharmacology: practice and contexts. Oxford: Oxford University Press; 2013. p. 3-19.
8. Ofori-Atta A, Read U, Lund C. A situation analysis of mental health services and legislation in Ghana: challenges for transformation. Afr J Psychiatry. 2010;13:99-108.
9. Sanati A. Investigating the quality of psychotropic drug prescriptions at Accra Psychiatric Hospital. Int Psychiatry. 2009;6:69-70.
10. Avokat D, Mayville E, Matsn L. Side effect profiles of atypical antipsychotics, typical antipsychotics, or no psychotropic medications in persons with mental retardation. Res Dev Disabil. 2000;21(1):75-84.
11. Attride-Stirling J. Thematic networks: an analytic tool for qualitative research. Qual Res. 2001;1(3):385-405.
12. Ministry Of Health. Standard Treatment Guidelines 2010; 159-176.
13. Antwi-Bekoe T, Deme-Der DNW, Donnir GM, Raja S, Yaro P. Psychotropic medicine shortages in Ghana: a situation analysis. GIJMH. 2009;1(1):157-70.
14. Martin DC. The mental status examination. In: Walker HK, Hall WD, Hurst JW, editors. Clinical methods: the history, physical, and laboratory examinations. Boston: Butterworths; 1990. p. 207.
15. Miller D. Atypical antipsychotics. sleep, sedation, and efficacy. Prim Care Companion J Clin Psychiatry. 2004;6:3-7.